Alinia Powder For Oral Suspension 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Alinia: Powder for oral suspension (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Alinia 100mg/5ml Pwd for Susp

What is this Medicine?

NITAZOXANIDE (nye ta ZOX a nide) is an anti-infective. It is used to treat diarrhea caused by some parasites.

CVS Pharmacy Patient Statistics for Alinia: Powder for oral suspension(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Alinia 100mg/5ml Powder for Suspension

NDC: 675460212
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Cryptosporidiosis, Infectious Diarrhea, Giardiasis

Sometimes used for but not FDA approved for the following conditions:
Microsporidiosis, Pseudomembranous Colitis, Rotavirus Infection

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Alinia 100mg/5ml Powder for Suspension

Reported Side Effects for Alinia 100mg/5ml Powder for Suspension

High White Blood Cells Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Muscle Cramps Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
<1.1%*
Severity: MILD
Onset: EARLY
Causing To Be Hungry Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Broken Bones Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hypoesthesia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Change In Eye Color Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Ear Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Pelvic Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Urine Discoloration Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
No Menstrual Periods Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Painful Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
1.1-3.1%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
2.1-4.2%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
6.6-7.8%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Alinia

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.